Position in PFE
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$673,421
-$106,585 QoQ
Shares Held
27,966
+0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.30%
of 13F equity value
Holder Rank
#1,555
of 2,820 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Code Waechter LLC holds $5,749,721 across 9 Drug Manufacturers - General names. PFE ranks #3 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
5,102 | $1,283,867 | |
| 2 | LLY |
ELI LILLY & Co
|
710 | $851,595 | |
| 3 | PFE |
Pfizer Inc
This page
|
27,966 | $673,421 | |
| 4 | JNJ |
Johnson & Johnson
|
2,607 | $662,099 | |
| 5 | AMGN |
Amgen Inc
|
1,786 | $646,746 | |
| 6 | SNY |
Sanofi
|
13,905 | $593,187 | |
| 7 | GSK |
GSK plc
|
8,535 | $447,404 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,537 | $320,524 |
All Filings in PFE
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $673,421 | 27,966 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $780,006 | 27,778 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $687,638 | 27,616 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $573,580 | 22,511 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $499,344 | 20,600 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $335,146 | 13,226 | Shares | Sole | 2025-04-30 | |
| No filing history on record for this holder in this stock. | ||||||